StrataXRT for Radiation Burn
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a treatment called StrataXRT, a silicone-based gel, to determine if it reduces skin issues caused by radiation therapy in breast cancer patients. These skin problems can include redness, itching, and, in severe cases, skin breaking. The trial seeks women with large breasts who have breast cancer and will receive radiation therapy while lying on their stomachs. Participants will apply the gel twice daily during and after their radiation treatment to assess its effectiveness in preventing or lessening these skin reactions. As an unphased trial, this study allows participants to contribute to research that could enhance comfort and outcomes for future patients undergoing radiation therapy.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are receiving cytotoxic chemotherapy (a type of cancer treatment that uses drugs to kill cancer cells).
What prior data suggests that StrataXRT is safe for treating radiation dermatitis?
Research has shown that StrataXRT is generally safe and well-tolerated by patients. In past studies, this silicone-based gel effectively managed skin problems such as redness, itching, and swelling caused by radiation therapy. Importantly, these studies reported no major side effects, suggesting that StrataXRT is safe for use on skin affected by radiation. Patients in these studies applied the gel twice a day, which helped reduce the severity of their skin reactions. Therefore, for those considering joining a trial with StrataXRT, existing evidence supports its safety in humans.12345
Why are researchers excited about this trial?
Unlike other treatments for radiation burns, StrataXRT is a topical gel specifically designed to support skin healing when it's most vulnerable during and after radiation therapy. Most current treatments rely on general wound care products like aloe vera gels or corticosteroid creams, which provide soothing relief but do not specifically target the unique needs of radiation-damaged skin. StrataXRT is unique because it forms a protective film over the affected area, helping to maintain a moist healing environment crucial for skin recovery. Researchers are excited about StrataXRT because it promises a more targeted approach, potentially reducing the severity of radiation burns and improving patient comfort during a difficult treatment phase.
What evidence suggests that StrataXRT might be an effective treatment for radiation dermatitis?
Research has shown that StrataXRT can help reduce skin problems such as redness, itching, and peeling in breast cancer patients undergoing radiation therapy. Studies have found that it lowers the risk of severe skin reactions by up to 49.4%. In this trial, all participants will receive StrataXRT to evaluate its effectiveness in preventing serious skin issues. Notably, previous studies indicated that patients using StrataXRT while lying face down experienced the best results. These findings suggest that StrataXRT could be a helpful option for managing skin side effects during radiation therapy.14678
Are You a Good Fit for This Trial?
This trial is for large-breasted women with breast cancer who are receiving adjuvant radiation therapy. It's specifically looking at those using a prone technique to reduce skin reactions. Participants must meet certain health criteria, but specific inclusion and exclusion details aren't provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation Treatment
Participants receive adjuvant breast radiation treatment using a prone technique, with StrataXRT applied daily
Post-Treatment
Participants continue to apply StrataXRT for a minimum of 2 weeks post-radiation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of radiation dermatitis and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- StrataXRT
Trial Overview
The study tests StrataXRT, a silicone-based gel, to see if it can prevent or lessen radiation dermatitis—a common side effect of radiation treatment that causes skin irritation and breakdown—in these patients.
How Is the Trial Designed?
All patients will receive StrataXRT for the duration of their treatment. RT will be delivered as prescribed by the treating radiation oncologist and may include a variety of techniques and beam modifiers. A trained CRA will teach the patient how to apply StrataXRT prior to their first RT at a designated clinic room and will perform daily checks prior to radiation for the first week of treatment to ensure that the patient has covered the entire treatment area. StrataXRT will be used by the patients daily during their entire treatment, and for a minimum of 2 weeks post-RT. As recommended by the product monograph, patients will be asked to apply StrataXRT twice daily, once in the morning and once in the evening. Additionally, as suggested in the monograph, patients will be directed to reapply the gel any time after they take a shower or if they notice the film is no longer covering the treatment area.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor
Citations
StrataXRT for the prevention of acute radiation dermatitis in ...
Conclusion: StrataXRT may help prevent severe acute RD in breast cancer RT patients. Further high quality, large-scale studies are needed to ...
StrataXRT for the Prevention and Treatment of Radiation ...
This clinical trial studies the effect of StrataXRT in preventing and treating radiation dermatitis in breast cancer or head and neck cancer patients.
Clinical efficacy in radiation dermatitis treatment
“StrataXRT was not inferior to Mepitel Film on the reported outcome measures of occurrence of moist desquamation, worst grade of acute radiation dermatitis ...
A single-blind, randomised controlled trial of StrataXRT® – ...
Cox regression analysis showed that patients receiving StrataXRT® had a 41.0% and 49.4% reduced risks of developing grade 2 and 3 skin toxicity respectively ...
StrataXRT for the prevention of acute radiation dermatitis in ...
Conclusion: StrataXRT is effective in preventing grade 3 RD in patients, and the most promising results were observed within the prone cohort.
StrataXRT wound dressing for radiation dermatitis
StrataXRT is recommended to be used following the initial radiation dose and should be applied continuously for a minimum of 60–90 days (24 hours a day / 7 days ...
A new approach in the management of radiation dermatitis
StrataXRT is indicated for use on all types of radiation dermatitis, toxic and compromised skin and superficial wounds resulting from radiation therapy.
Reducing Radiation Dermatitis Using a Film-forming Silicone ...
Studies have raised the possibility that topical use of StrataXRT might be effective in reducing various types of radiation-induced skin reactions (27,28). A ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.